SCHEMBL28296842

SCHEMBL28296842

CN1CCC(c2cc(F)cc(F)c2)C1.NC=S

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
KCNH2 Q12809 1/20 0.37
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR1E P28566 1/20 0.36
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
HTR3A P46098 1/20 0.36
HTR5A P47898 1/20 0.36
QDPR P09417 1/20 0.35
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823938 0.92 SLC6A2 (0.41) NPC1RAB9ASMN1; SMN2SLC6A2SLC6A4
SCHEMBL10078850 0.81 QDPR (0.50) SLC6A2SLC6A4SLC6A3HTR2AHTR2C
SCHEMBL1822634 0.81 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3KCNH2HTR1A
SCHEMBL28298518 0.78 QDPR (0.33) SLC6A2SLC6A4SLC6A3KCNH2HTR1A
SCHEMBL28296849 0.77 DRD2 (0.47) HTR1AHTR1DHTR1BHTR2AHTR2C
SCHEMBL10078852 0.75 DRD2 (0.51) SLC6A2SLC6A4SLC6A3KCNH2HTR1A
SCHEMBL13416053 0.74 NPC1 (0.47) NPC1RAB9ASLC6A2SLC6A4SLC6A3
SCHEMBL2606075 0.74 NPC1 (0.47) NPC1RAB9ASLC6A2SLC6A4SLC6A3
SCHEMBL13242901 0.73 QDPR (0.44) HTR1DHTR1BQDPR
SCHEMBL28298511 0.72 BRD4 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715155-A blood brain barrier-penetrating agent dopamine- β -hydroxylase inhibitors 巴尔-波特拉及康邦亚股份有限公司 2019-05-03 CN disclosed